Noel L. Mills

INTERPOSITION OF SURAL NERVE RESTORES FUNCTION OF CAVERNOUS NERVES RESECTED DURING RADICAL PROSTATECTOMY

PURPOSEnThe permanent loss of erectile function when both neurovascular bundles are widely resected at radical prostatectomy as well as the successful use of autologous nerve grafts in reconstructive surgery led us to perform bilateral nerve grafts in an effort to restore erectile function in potent patients treated for prostate cancer who underwent radical retropubic prostatectomy and resection of both neurovascular bundles.nnnMATERIALS AND METHODSnRadical retropubic prostatectomy with deliberate resection of both neurovascular bundles was recommended for high grade, locally extensive prostate cancer in 9 select, sexually active men who reported normal erectile function. After the prostate was removed but before vesicourethral anastomosis an autologous sural nerve graft was interposed between the divided ends of the cavernous nerves bilaterally. Erectile function was monitored by patient interview, questionnaire and nocturnal penile tumescence testing after the operation.nnnRESULTSnFour to 5 months postoperatively patients noticed slowly improving spontaneous erections, as manifested by mild tumescence regularly every several hours. Nocturnal penile tumescence testing with the RigiScan device at 4 to 6 months in 2 cases revealed erections that approached minimal criteria for normalcy. Approximately 14 months after surgery a rigid erection sufficient for penetration and intercourse developed in 1 patient. He described this event as an erection of substance-hard, not just fluffy.nnnCONCLUSIONSnWe have developed a technique using sural nerve grafts to restore continuity of the cavernous nerves, which are resected during radical prostatectomy. The early return of spontaneous partial erections in our patients suggests that interposition nerve grafts may enhance the recovery of erectile function when the neurovascular bundles are resected.

Technical advances in the treatment of left ventricular aneurysm

The resulting abnormal geometry after surgical treatment of left ventricular aneurysm has concerned a number of surgeons since the first successful repair in 1958, but little attention was placed on the altered geometry until attempts were made to effect a more physiologic aneurysmorrhaphy in 1973. Substantial attention was focused on a concept of geometric reconstruction from within the left ventricle in 1985. A prosthetic patch was employed with the concept to redirect normal muscle bundles to their original orientation and position. Further refinements include use of improved materials for the repair, preservation and bypass of the left anterior descending coronary artery, ablation of ventricular arrhythmias when indicated, and the absence of prosthetic material used in contact with the pericardial surface. Our experience with repair of 61 left ventricular aneurysms at West Jefferson Medical Center over a 4 1/2-year period with a 3.3% mortality rate has prompted a change from the standard linear repair to routine use of a modified endoventricular repair. Currently, the low surgical risk due to advances in left ventricular aneurysmorrhaphy combined with the knowledge that contractile areas will progressively deteriorate in ventricles stressed by poor hemodynamics and with data showing improved left ventricular function postoperatively have led to more liberal recommendations for early left ventricular aneurysm repair.

Measurement of atrial septal defect during cardiac catheterization. Experimental and clinical results.

The size of experimental and clinical secundum atrial septal defects may be accurately measured during cardiac catheterization. The position of the defects in the septum and their distance from the aortic and mitral valves may also be ascertained. A balloon catheter inflated with radiopaque dye is used for the measurement. The volume of dye in the balloon has been correlated with its maximal diameter. Thus, a no. 8-10 French catheter filled with 10 ml of diatrizoate (50 percent) has a diameter of approximately 25 mm and a no. 8-22 French catheter filled with 40 ml of diatrizoate a diameter of approximately 43 mm. Persistent arrhythmias or other adverse effects of the procedure were not observed. There was a high correlation between balloon-measured atrial septal defects and those measured at necropsy in the animals or at operation in the patients. These measurements aid in determining whether an ostium secundum defect is of proper size and location to be closed transvenously and may also prove valuable in physiologic studies of atrial septal defects or other cardiac anomalies.

Vein graft failure.

Saphenous vein graft failure is one of the primary reasons for coronary artery bypass reoperation. The economic impact alone in this country is staggering in an era of intensive cost cutting. The fact that some vein grafts remain free of disease for years while the sibling vein develops extensive atherosclerosis remains an enigma. Saphenous vein valves have recently attracted interest. Repeated angiograms show that vein graft disease invariably is accentuated around valves. Studies show that the segment of saphenous vein distal to the valves have more accelerated and intense atherosclerosis. Early results of saphenous vein bypass grafting may be predicted with some degree of certainty by saphenous vein graft biopsy. Attention is now being turned to the hypercoagulable state as a cause of graft failure, as this has not been previously addressed. Research into pharmacologic agents for maintaining open grafts has had disappointing results and aspirin alone is still the single drug of choice to promote patency. Preparation of the graft continues to be important because there is direct evidence that surgical injury during preparation leads to neointimal thickening and vascular smooth muscle proliferation. Although there are some exciting new modalities for preventing graft disease, the difficulty in transposing animal data to humans and the uncertainty of the biologic similarities of in vitro and in vivo endothelial cell biochemistry makes any immediate solution unlikely. Therefore an even greater increase in the use of arterial grafts in the near future seems likely, even with their associated problems.

Technique for use of the inferior epigastric artery as a coronary bypass graft

A search for a coronary bypass conduit with increased longevity has resulted in harvest of the inferior epigastric artery. The artery is dissected through a paramedian incision with retraction of the rectus muscle to the lateral side. As the inferior epigastric artery courses superiorly, it may lie in one of three positions in relation to the rectus muscle. Distal coronary anastomoses using this conduit are conventional, and the proximal anastomosis may be made to the aorta or end-to-side to an internal mammary artery or venous conduit. After preparation with dilute papaverine-Plasmalyte solution proximal sizes have ranged from 2.5 to 3.25 mm (internal diameter), and distal inferior epigastric artery sizes measured 1.5 to 2.5 mm (internal diameter). The lengths of the conduit ranged from 11.5 to 17.0 cm. Eighteen patients aged 41 to 74 years had inferior epigastric artery grafts to 19 coronary arteries. The indications for use were absent or poor-quality vein, young age with an attempt to limit vein graft, and avoidance of use of bilateral internal mammary artery grafts in insulin-dependent diabetic patients. There was one sterile wound hematoma and one late wound infection. There were no other infections and no deaths. Three patients studied postoperatively revealed widely patent inferior epigastric artery grafts.

Late follow-up of nonoperative closure of secundum atrial septal defects using the King-Mills double-umbrella device

There has been a marked increase in device closure of secundum atrial septal defects (ASDs) in the last decade. No clinical reports of late results have been forthcoming until now. The purpose of this report was to provide very long-term follow-up of nonoperative closure of secundum ADSs using the King-Mills Umbrella device. ASD closure using this technique did not appear to protect against the known secundum ASD complication of atrial arrhythmia. Twenty-seven-year follow-up of the umbrella ASD closure via the femoral vein shows effective occlusion, absence of device complications, and no reinterventions.

Technical Considerations for Myocardial Protection during the Course of Coronary Artery Bypass Reoperation: The Impact of Functioning Saphenous Vein and Internal Mammary Artery Grafts

New technical challenges involving the delivery of cardioplegia during the course of coronary artery bypass operation continue to be presented to the surgeon. Functioning saphenous grafts at reoperation that are at risk for distal embolization, are managed by altering the standard cardioplegia delivery techniques. Management of patent internal mammary artery (IMA) grafts depends upon the status of the native circulation and coronary collateral. The reoperation may be performed with a fibrillating heart, standard cardioplegia with a clamped mammary graft, or cardioplegia delivered during simultaneous circulatory arrest. Myocardial temperature measurements, during the course of more complex operations, are useful in choosing the appropriate technique for myocardial protection.

“Legs” technique for management of widely separated coronary arteries during ascending aortic repair

BACKGROUNDnWidely separated coronary arteries with significantly diseased tissue continues to challenge surgeons repairing ascending aortic aneurysms.nnnMETHODSnOccasional troublesome leaks around coronary ostial anastomoses and Cabrol graft thrombosis prompted a change of our operative management of this condition. Collagen-impregnated 8-mm legs grafts are used to connect the coronary arteries to the composite graft. Ten patients, aged 14 to 70 years, underwent the operation.nnnRESULTSnThe first patient is 15 years after the operation and is symptom free. One patient died of an arrhythmia 1 month after discharge. Eight patients are living and well 11/2 to 4 years postoperatively.nnnCONCLUSIONSnAdvantages of direct interposition (legs) grafts are as follows: the coronary arteries are separately perfused and the risk of catastrophic thrombosis from a longer high-volume graft is eliminated. Problems with coronary ostial mobilization are avoided. The technique allows full visualization and hemostatic suture line testing with cardioplegia before aortic declamping. Space constraints with reoperations are easily managed, whereas other techniques may result in graft compression on refilling of the heart and termination of bypass. The technique is carried out with ease and reproducibility, and the availability of new graft material has made it our treatment of choice for ascending aortic composite graft replacement.

Reoperative coronary artery bypass grafting.

In recent years reoperative coronary artery bypass surgery has become increasingly more commonplace. This article reviews the current status of this procedure with regard to patient population, risk factors, and long-term follow-up. Important aspects of the specific technical considerations involved in reoperative surgery are also reviewed and evaluated.

Comparative effects of endothelin (ET-1) and U46619 on human saphenous vein and gastroepiploic artery, sources of human autologous grafts

The effects of endothelin (ET-1) on smooth muscle contractile activity were investigated and compared in human saphenous vein and gastroepiploic artery, vessels frequently used in revascularization procedures. ET-1 contracted saphenous vein and gastroepiploic artery in a concentration-dependent manner. The peptide produced a greater maximal effect in the vein than in the artery and, in both preparations, ET-1 was less efficacious than U46619, an agent which mimics the actions of thromboxane A2 at the thromboxane A2/prostaglandin HZ receptor. The contractile response to ET-1 declined spontaneously at a more rapid rate in the artery than in the vein. The present data indicate that ET-1 has significant contractile activity in both vessels which are used for coronary arterial bypass surgery and suggest that although, a weaker vasoconstrictor than U46619, the peptide could induce vasospasm in both graft vessels.